OABI

OABI

USD

OmniAb Inc. Common Stock

$1.700-0.050 (-2.857%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.750

Hoch

$1.750

Tief

$1.690

Volumen

0.87M

Unternehmensfundamentaldaten

Marktkapitalisierung

214.1M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.12M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $1.22Aktuell $1.700Hoch $4.96

Ähnliche Nachrichten

BusinessWire

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three months ended March 31, 2025, and provided operating and partner program

Mehr anzeigen
OmniAb Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

ZURICH, SWITZERLAND, May 5, 2025 -- VERAXA Biotech AG ("VERAXA"), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, "Voyager")),

Mehr anzeigen
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
BusinessWire

OmniAb Announces Two New Appointments to its Board of Directors

Philip Gotwals, Ph.D. and Steve Crouse bring strategic and operational experience in business development and global tools and technology OmniAb, Inc. (NASDAQ:OABI) today announced the appointments of Philip J.

Mehr anzeigen
OmniAb Announces Two New Appointments to its Board of Directors